Pharmaceutical companies outsource drug manufacturing to CDMOs (contract development and manufacturing organizations) or CMOs (contract manufacturing organizations) because they need access to capacity or technological capabilities beyond what they have in-house and mitigate risk by outsourcing to a secondary supplier.
A contract manufacturing company provides an option to pharma companies with drug formulas that are ready to go, whereas full-service CDMOs provide pharma development services in addition to the manufacturing services a CMO offers.
When pharmaceutical companies consider a CMO vs a CDMO, wide-ranging CDMO services, including commercial drug manufacturing , research and development, analysis, clinical trials, and post-marketing product support, offer more flexibility, consistency, and expertise, making CDMOs the preferred choice even for pre-formulated drugs. Advancing from a CMO to a CDMO provides greater opportunities for innovation and specialization.
Benefits of CDMO Services In Pharma Development & Manufacturing
Among the many pressures that pharmaceutical companies face is the need to invest in equipment, technology, and expertise, meeting the demands of global supply chains and reducing costs without compromising product quality and patient safety. Partnering with top CDMOs provides the following benefits to your company: End-to-End Pharmaceutical Expertise
CDMOs offer access to additional expertise by offering researchers who have the needed experience and specialized skills at each stage of drug development and manufacturing without increasing payroll costs.
Provided Equipment & Facilities :
A wide range of equipment is required for manufacturing various drug forms, and the costs are high. Partnering with a CDMO reduces or eliminates the need to build and staff and invest in expensive equipment.
Ability to Scale Drug Projects :
Adding a new drug variation or shifting production volume to meet increased demand can put a project at risk through failure to meet production deadlines or maintain quality and homogeneity. Using a CDMO for scale-up support reduces the risk and shortens lead times.
Full-service CMDOs allow pharmaceutical companies to stay nimble and lean while receiving extensive, differentiated drug development and support. Such specialized CDMO services ensure greater flexibility and manageable cash flow than would be achievable internally. Furthermore, outsourcing frees up time and resources to focus on drug discovery and marketing, pushing the pharma industry forward.
Glass reactors & process equipment
Ai glass reactors and process equipment guarantee best process performance in labs, pilot plants / kilo labs and production. From laboratory synthesis through scale-up to production
Ai apparatus and systems are built quality borosilicate glass components and various other components made of highly corrosion-resistant materials such as glass-lined steel etc. Request a quote today on our Glass reactors and other lab equipment.